Aspiriant LLC’s MyoKardia, Inc. Common Stock MYOK Stock Holding History

Aspiriant LLC’s Portfolio MYOK Stock Details MYOK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-1,775	Closed	-$242K	–	227
2020 Q3	$242K	Buy	+1,775	New	+$189K	0.02%	197

Aspiriant LLC's MYOK Position: Q4 2020 in Review

Aspiriant LLC sold out of MyoKardia, Inc. Common Stock (MYOK) in Q4 2020, closing a stake of 1,775 shares — an estimated $242K sold.

Aspiriant LLC first reported a position in MYOK in Q3 2020 and held it in 1 quarter. The position peaked at $242K in Q3 2020. 0 funds tracked by Wall St. Rank hold MYOK as of Q4 2020.

Aspiriant LLC reported no remaining MyoKardia, Inc. Common Stock position as of Q4 2020 after selling out during the quarter.
Aspiriant LLC sold 1,775 MyoKardia, Inc. Common Stock shares in Q4 2020, an estimated $242K.
Aspiriant LLC first reported a position in MyoKardia, Inc. Common Stock in Q3 2020 and held it in 1 quarter.
Aspiriant LLC's MyoKardia, Inc. Common Stock position peaked at $242K in Q3 2020.
0 funds tracked by Wall St. Rank held MyoKardia, Inc. Common Stock as of Q4 2020.

Based on Aspiriant LLC's 13F filing for Q4 2020, filed 1 Feb 2021.